Sirona Biochem Corp.
SRBCF · OTC
10/31/2023 | 10/31/2022 | 10/31/2021 | 10/31/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $1 | $0 | $0 |
| % Growth | -94.8% | 150.7% | 153.5% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $1 | $0 | $0 |
| % Margin | -82.7% | 92.5% | 74.3% | 48.8% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $1 | $3 | $1 | $3 |
| SG&A Expenses | $1 | $3 | $1 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $4 | $3 | $4 |
| Operating Income | -$2 | -$4 | -$2 | -$4 |
| % Margin | -6,917.6% | -531.1% | -875.8% | -3,821.3% |
| Other Income/Exp. Net | -$0 | $0 | $0 | -$0 |
| Pre-Tax Income | -$3 | -$4 | -$2 | -$4 |
| Tax Expense | -$0 | $0 | -$0 | -$0 |
| Net Income | -$3 | -$4 | -$2 | -$4 |
| % Margin | -7,312.4% | -529.5% | -860.5% | -3,910.4% |
| EPS | -0.01 | -0.015 | -0.01 | -0.018 |
| % Growth | 31.8% | -46.5% | 44.8% | – |
| EPS Diluted | -0.01 | -0.015 | -0.01 | -0.018 |
| Weighted Avg Shares Out | 252 | 241 | 229 | 226 |
| Weighted Avg Shares Out Dil | 252 | 241 | 229 | 226 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$4 | -$2 | -$4 |
| % Margin | -6,707.4% | -523.2% | -857.8% | -3,895.5% |